As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation? (LLY:NYSE) - Seeking Alpha
Track next-gen GLP-1 obesity & metabolic drugs—oral pills, triple agonists, combos—plus U.S. pricing and coverage impacts on Lilly and rivals.